Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients

Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life ...

An experimental combination of radiation therapy and gene therapy is effective and safe for treating various tumors

Researchers plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy ...
dvm360

Do you speak cat? Decoding feline communication and teaching clients to do the same

Alejandre, Assistant Editor Most clients can't read their cats. Tiffany Tupler, DVM, CBCC-KA, HAB, explains why that's a ...

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026

Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme ...
dvm360

CAPC forecasts expanding parasite risk in 2026, including Lyme disease, heartworm, ehrlichiosis, and anaplasmosis

CAPC’s 2026 forecast shows Lyme disease, heartworm, ehrlichiosis and anaplasmosis expanding nationwide, urging year-round ...

Karmanos Cancer Institute Becomes First and Only Free-Standing Cancer Center to Treat Hemophilia B with New Gene Therapy

The Barbara Ann Karmanos Cancer Institute has become the first and only independent cancer center in the U.S. to provide a ...